Citigroup Downgraded Eloxx Pharmaceuticals, Inc. ($ELOX) to Neutral from Buy rating; Price Target contracted to $ 4.00 down from previous mark of $ 11.00
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=ELOX’ sec=’1′]
